These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20695946)

  • 1. Raised plasma urotensin II in type 2 diabetes patients is associated with the metabolic syndrome phenotype.
    Gruson D; Rousseau MF; Ketelslegers JM; Hermans MP
    J Clin Hypertens (Greenwich); 2010 Aug; 12(8):653-60. PubMed ID: 20695946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raised natriuretic peptides, big-endothelin-1 and improved beta-cell function in type 2 diabetic males with hyperuricaemia.
    Hermans MP; Ahn SA; Rousseau MF
    Diab Vasc Dis Res; 2009 Jul; 6(3):190-3. PubMed ID: 20368210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy.
    Totsune K; Takahashi K; Arihara Z; Sone M; Murakami O; Ito S; Kikuya M; Ohkubo T; Hashimoto J; Imai Y
    Peptides; 2004 Oct; 25(10):1809-14. PubMed ID: 15476950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma urotensin II levels in patients with diabetes mellitus.
    Totsune K; Takahashi K; Arihara Z; Sone M; Ito S; Murakami O
    Clin Sci (Lond); 2003 Jan; 104(1):1-5. PubMed ID: 12519081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans.
    Khan SQ; Bhandari SS; Quinn P; Davies JE; Ng LL
    Int J Cardiol; 2007 May; 117(3):323-8. PubMed ID: 16887216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does cigarette smoking increase plasma urotensin II concentrations?
    Gold SJ; Thompson JP; Williams JP; Helm EE; Sadler J; Song W; Ng LL; Lambert DG
    Eur J Clin Pharmacol; 2007 Mar; 63(3):253-7. PubMed ID: 17252242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the effect of adrenomedulin and urotensin-II on pulmonary hypertension of patients with congenital heart disease].
    Wang T; Li SX; Zhang XQ; Gu XH; Song Y; Zhang G; Wu SM
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(38):2691-5. PubMed ID: 16324296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study.
    Zengin H; Erbay AR; Okuyucu A; Alaçam H; Yüksel S; Meriç M; Soylu K; Gedikli Ö; Murat N; Gülel O; Demircan S; Akın F; Yılmaz Ö; Şahin M
    Anatol J Cardiol; 2015 Jun; 15(6):475-9. PubMed ID: 25430414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between urotensin II and insulin resistance in women with gestational diabetes mellitus.
    Calan M; Arkan T; Kume T; Bayraktar F
    Hormones (Athens); 2019 Mar; 18(1):91-97. PubMed ID: 30471011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is elevated urotensin II level a predictor for increased cardiovascular risk in subjects with acromegaly?
    Demirpence M; Guler A; Yilmaz H; Sayin A; Pekcevik Y; Turkon H; Colak A; Ari EM; Aslanipour B; Kocabas GU; Calan M
    J Endocrinol Invest; 2019 Feb; 42(2):207-215. PubMed ID: 29804270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of the vasoactive peptide urotensin II in patients with acute coronary syndrome and stable coronary artery disease.
    Al Kindi H; Hafiane A; You Z; Albanese I; Pilote L; Genest J; Schwertani A
    Peptides; 2014 May; 55():151-7. PubMed ID: 24642358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Leptin in Patients at Intermediate to High Cardiovascular Risk With and Without Type 2 Diabetes Mellitus.
    Montagnana M; Fava C; Targher G; Franchini M; Danese E; Bonafini S; De Cata A; Salvagno GL; Ruzzenente O; Guidi GC; Lippi G
    J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27470535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers.
    Gruson D; Rousseau MF; Ahn SA; van Linden F; Ketelslegers JM
    Peptides; 2006 Jun; 27(6):1527-31. PubMed ID: 16364499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia.
    Ban Y; Watanabe T; Suguro T; Matsuyama TA; Iso Y; Sakai T; Sato R; Idei T; Nakano Y; Ota H; Miyazaki A; Kato N; Hirano T; Ban Y; Kobayashi Y
    J Atheroscler Thromb; 2009 Jun; 16(3):179-87. PubMed ID: 19638714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of changes of urotensin II in patients with congestive heart failure].
    Zhong P; Li ZL; Wu HC; Tang CS; Lu Q
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):121-3. PubMed ID: 12581957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of urotensin II on skin microvessel tone in diabetic patients without heart failure or essential hypertension.
    Zomer E; de Ridder I; Kompa A; Komesaroff P; Gilbert R; Krum H
    Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1147-50. PubMed ID: 18505448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A closer look at the role of urotensin II in the metabolic syndrome.
    Barrette PO; Schwertani AG
    Front Endocrinol (Lausanne); 2012; 3():165. PubMed ID: 23293629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal impairment, hypertension and plasma urotensin II.
    Mosenkis A; Kallem RR; Danoff TM; Aiyar N; Bazeley J; Townsend RR
    Nephrol Dial Transplant; 2011 Feb; 26(2):609-14. PubMed ID: 20621933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of increased urotensin II levels in acute myocardial infarction.
    Zhang X; Ye Y; Yang C; Gong H; Li Y; Zhang G; Yuan J; Zou Y
    Discov Med; 2018 Aug; 26(141):7-20. PubMed ID: 30265851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic Changes in Plasma Urotensin II and Its Correlation With Plaque Stability.
    Yin CL; Liu X; Wang HX; Yan MC; Guo LJ; Li GN; Xia JG; Yuan HH; Yin Y
    J Cardiovasc Pharmacol; 2021 Jul; 78(1):e147-e155. PubMed ID: 34173803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.